Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Slowing Sales for Johnson & Johnson's Zytiga May Be Good News for Medivation
Slowing Sales for Johnson & Johnson's Zytiga May Be Good News for Medivation
Slowing Sales for Johnson & Johnson's Zytiga May Be Good News for Medivation
Submitted by
admin
on January 23, 2014 - 8:22am
Source:
Motley Fool
News Tags:
JNJ
Zytiga
Medivation
Xtandi
prostate cancer
Headline:
Slowing Sales for Johnson & Johnson's Zytiga May Be Good News for Medivation
Do Not Allow Advertisers to Use My Personal information